Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.530
+0.020 (0.57%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $190.55 million as of April 25, 2025. Its market cap has decreased by -63.59% in one year.
Market Cap
190.55M
Enterprise Value
-47.24M
1-Year Change
-63.59%
Ranking
Category
Stock Price
$3.53
Market Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has decreased from $301.64M to $190.55M, a decrease of -36.83%. That is a compound annual growth rate of -7.65%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 744.81B |
| UnitedHealth Group | 389.54B |
| Johnson & Johnson | 374.44B |
| AbbVie | 313.20B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.18B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |